Co-founder and CEO, Dr. Manish Agrawal, recently shared his expertise and vision for the future of psychedelic-assisted therapy in oncology in a four-part interview series with @Pharmacy_Times' Lead Editor, Alana Hippensteele. This series offers a nuanced look at the evolving

In the evolving world of psychedelic-assisted therapy, one truth stands out: expectations shape experience. But what happens when those expectations lead to disappointment?. In our latest blog on @PsychToday , Sunstone Therapist Dr. Mark Bates explores why naming potential

Join Sunstone’s Therapist Program Director, Rachel Winzer, and guest speaker, Dr. Nadav Liam Modlin, Psychology & Psychotherapy Lead in Psychedelics at King’s College London, to discuss how to provide personalized therapeutic care while upholding rigorous research protocols.

The study, exploring psilocybin-assisted therapy for cancer patients experiencing depression, reflects years of work to bring compassionate, evidence-based care to those navigating the emotional weight of a cancer diagnosis. It investigates how a single dose of psilocybin,.

We're honored to see our most recent research highlighted in @OprahDaily —and even more grateful that it's reaching those who may benefit most. To see this work resonate beyond the academic world is a reminder of why we do what we do.

Are you, or someone you know, curious about FDA-approved psychedelic-assisted therapy clinical trials? This innovative field is rapidly evolving, and we invite you to join our upcoming webinar to hear Dr. Manish Agrawal, Sunstone's CEO and Principal Investigator, as he discusses

How do you provide personalized therapeutic care while upholding rigorous research protocols? This crucial question is at the heart of our upcoming webinar for Therapists and Mental Health Providers. Join Sunstone's Rachel Winzer and King's College London's Dr. Nadav Liam Modlin

We’re pleased to announce the publication of our Long-term Benefits of Single-Dose Psilocybin in Depressed Patients with Cancer Study in @JournalCancer, the Journal of the American Cancer Society!. Led by our CEO and Principal Investigator, Dr. Manish Agrawal, this study.

Sunstone will be at @PsychedelicSci in Denver next week, and we’re looking forward to the meaningful conversations that always come from gathering with fellow researchers, scientists, and colleagues in the field. Here’s where to find us and join the dialogue!

Today, on International Clinical Trials Day, Sunstone celebrates the vital role clinical research plays in shaping the future of healthcare. We’re proud to contribute to this legacy through our work in psychedelic-assisted therapy, with a growing portfolio of active clinical

You're Invited: Open House for Mental Health Providers and Referring Clinicians. Join us in person on Tuesday, June 10 to connect with our clinical team, explore our ongoing clinical trials focused on complex mental health conditions, and learn more about the innovative care we

Therapists, join us for a focused conversation on preparation in psychedelic-assisted therapy. Sunstone’s Therapist Program Director, Rachel Winzer, will be joined by guest speaker Nadav Liam Modlin, Psychology & Psychotherapy Lead in Psychedelics at King’s College London.

Thank you, Melissa Lavasani and @PMCinDC Coalition, for inviting Sunstone’s CEO, Dr. Manish Agrawal, to be part of the Federal Summit on Psychedelic Medicine to speak about our work at Sustone and how we’re contributing to thoughtful, evidence-based integration of psychedelic